Drug Testing Locations - Reno, NV

Drug Testing in Reno, NV

Reno, Nevada Statistics

Reno, in Washoe County, recorded a 25% increase in opioid overdoses in 2022.

In Washoe County, nearly 50% of drug arrests were related to methamphetamine in 2021.

Reno has seen a 15% rise in drug-related emergency room visits in the past year.

The rate of drug abuse among young adults in Reno has increased by 10% annually since 2020.

Washoe County reported over 150 drug-induced deaths in the last two years.

Reno's drug rehabilitation centers have reached a 90% occupancy rate.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Reno, NV & Drug Testing Policies

Employers in Reno, NV, are implementing stringent drug testing policies to maintain a safe and productive work environment. Many businesses comply with federal drug-free workplace standards, and some partner with the state's Department of Employment, Training, and Rehabilitation for guidelines.

Companies recognize the importance of screening in industries where safety is critical. Random drug tests are increasingly becoming a part of the hiring process. The policy is detailed to all employees and often includes tests during the pre-employment phase and random checks.

Government Efforts with Drug Problems in Reno, NV

To combat drug problems in Reno, NV, government initiatives have focused on increasing access to treatment and recovery services. Local agencies are collaborating with state programs to ensure maximized outreach. The city has aligned its strategy with Nevada's SAPTA to enhance its response to abuse issues.

The Washoe County Health District has launched public health campaigns promoting awareness on the dangers of drug abuse. Additionally, partnerships with federal agencies, including the Substance Abuse and Mental Health Services Administration, aim to drive down incidence rates through education and community involvement.

Local Drug Busts & News in Reno, NV

In recent years, Reno, NV has seen an uptick in drug-related incidents, prompting increased law enforcement efforts. Local authorities have been actively working to combat drug trafficking, which has resulted in several significant busts. These efforts often uncover networks extending beyond the city, highlighting Reno's role as a strategic location for trafficking routes within Nevada.

One notable event took place when Reno police, in collaboration with federal agencies, intercepted a large shipment of illegal substances bound for distribution. This operation led to multiple arrests and the seizure of substantial quantities of drugs, including methamphetamines and opioids. The bust underscored the importance of inter-agency cooperation in tackling the complex drug trade challenges in the region.

Community outreach initiatives in Reno also play a vital role in addressing drug use and addiction. Local organizations work alongside law enforcement to provide education, support, and rehabilitation services aimed at reducing demand and helping those impacted by substance abuse. These collaborative efforts emphasize a balanced approach of enforcement and support, crucial in mitigating drug-related issues in the community.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Reno, NV. Trusted by employers nationwide for accurate results and exceptional service.

Nevada DOT/Non DOT Physicals

Nevada Vision Tests

Nevada Audiograms

Nevada Respirator Fit Tests

Nevada Lift Tests

Nevada Background Checks

Clinical Testing Services

TB Testing in NV

Diabetes Testing in NV

Infectious Disease Testing in NV

Sickle Cell Anemia Testing in NV

Women/Men's Health Testing in NV

Resources & Citations

Nevada 211

SAPTA Nevada

Washoe County Health District

Center for the Application of Substance Abuse Technologies

Nevada Drug Association

NNADAP

SAMHSA National Helpline

Find Treatment

Drug Testing Near Reno, NV

Spanish Springs, NV

North Valleys, NV

Copperfield, NV

Lemmon Valley-Golden Valley, NV

Mogul, NV

Verdi-Mogul, NV

Lemmon Valley, NV

Verdi, NV

Golden Valley, NV

Sun Valley, NV

Glendale, NV

Sparks, NV

Frequently Asked Questions

Customer Reviews